Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Litton

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of Surgical Oncology|November 11, 2014
Hereditary breast cancer syndromes and genetic testingThereasa A Rich, Ashley H Woodson, Jennifer Litton, et al.
Seminars in Oncology|May 23, 2009
Breast cancer before age 40 yearsCarey K Anders, Rebecca Johnson, Jennifer Litton, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 10, 2017
Evaluating the NCCN Clinical Criteria for Recommending <i>BRCA1</i> and <i>BRCA2</i> Genetic Testing in Patients With Breast CancerCaiqian Cropper, Ashley Woodson, Banu Arun, et al.
Journal of Cancer Research and Clinical Oncology|June 27, 2008
Clinical features associated with a favorable outcome following neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or youngerYesim Eralp, Terry L Smith, Kadri Altundağ, et al.
Breast Cancer Research and Treatment|February 23, 2018
Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutationsKatherine Clifton, Angelica Gutierrez-Barrera, Junsheng Ma, et al.
Annals of Surgical Oncology|December 27, 2025
Axillary Management after Neoadjuvant Endocrine Therapy (NET)Laura Leonard, Min Yi, Emma Wingate, et al.
Cancer Journal (Sudbury, Mass.)|January 23, 2013
USP-11 as a predictive and prognostic factor following neoadjuvant therapy in women with breast cancerSoley Bayraktar, Angelica M Gutierrez Barrera, Diane Liu, et al.
Cancer|May 19, 2011
Bisphosphonates and pathologic complete response to taxane- and anthracycline-based neoadjuvant chemotherapy in patients with breast cancerMariana Chavez-Macgregor, Erika Brown, Xiudong Lei, et al.
Clinical Breast Cancer|February 6, 2010
Clinicopathologic factors associated with involved margins after breast-conserving surgery for invasive lobular carcinomaEric J Silberfein, Kelly K Hunt, Kristine Broglio, et al.
The Breast Journal|March 20, 2015
Genotype-Phenotype Correlations by Ethnicity and Mutation Location in BRCA Mutation CarriersSoley Bayraktar, Michelle Jackson, Angelica M Gutierrez-Barrera, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Surgical Oncology|November 11, 2014
Hereditary breast cancer syndromes and genetic testingThereasa A Rich, Ashley H Woodson, Jennifer Litton, et al.
Seminars in Oncology|May 23, 2009
Breast cancer before age 40 yearsCarey K Anders, Rebecca Johnson, Jennifer Litton, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 10, 2017
Evaluating the NCCN Clinical Criteria for Recommending <i>BRCA1</i> and <i>BRCA2</i> Genetic Testing in Patients With Breast CancerCaiqian Cropper, Ashley Woodson, Banu Arun, et al.
Journal of Cancer Research and Clinical Oncology|June 27, 2008
Clinical features associated with a favorable outcome following neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or youngerYesim Eralp, Terry L Smith, Kadri Altundağ, et al.
Breast Cancer Research and Treatment|February 23, 2018
Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutationsKatherine Clifton, Angelica Gutierrez-Barrera, Junsheng Ma, et al.
Annals of Surgical Oncology|December 27, 2025
Axillary Management after Neoadjuvant Endocrine Therapy (NET)Laura Leonard, Min Yi, Emma Wingate, et al.
Cancer Journal (Sudbury, Mass.)|January 23, 2013
USP-11 as a predictive and prognostic factor following neoadjuvant therapy in women with breast cancerSoley Bayraktar, Angelica M Gutierrez Barrera, Diane Liu, et al.
Cancer|May 19, 2011
Bisphosphonates and pathologic complete response to taxane- and anthracycline-based neoadjuvant chemotherapy in patients with breast cancerMariana Chavez-Macgregor, Erika Brown, Xiudong Lei, et al.
Clinical Breast Cancer|February 6, 2010
Clinicopathologic factors associated with involved margins after breast-conserving surgery for invasive lobular carcinomaEric J Silberfein, Kelly K Hunt, Kristine Broglio, et al.
The Breast Journal|March 20, 2015
Genotype-Phenotype Correlations by Ethnicity and Mutation Location in BRCA Mutation CarriersSoley Bayraktar, Michelle Jackson, Angelica M Gutierrez-Barrera, et al.
Pageof 3